Aptitude

Aptitude Medical Systems is a biotechnology company specializing in the development of next-generation aptamer-based technologies for diagnostics and therapeutics. The company's proprietary Metrix platform enables lab-quality molecular testing in a handheld, consumer-friendly format, facilitating decentralized healthcare and point-of-care diagnostics. By utilizing synthetic aptamers rather than traditional antibodies, Aptitude offers significant advantages in molecular stability, manufacturing cost, and rapid development cycles. Their lead product, the Metrix COVID-19 Test, received FDA Emergency Use Authorization for both over-the-counter and professional use. The company is expanding its pipeline to include multiplex tests for respiratory infections and is exploring therapeutic applications of its aptamer discovery platform.